The use of FDG-PET to target tumors by radiotherapy (Q37785001)

23 August 2017

The use of FDG-PET to target tumors by radiotherapy (English)

1 reference

23 August 2017

0 references

2

Dirk De Ruysscher

1 reference

23 August 2017

3

Angela van Baardwijk

1 reference

23 August 2017

8

Michel Ollers

1 reference

23 August 2017

5

Jacques Borger

1 reference

23 August 2017

4

Brigitta G Baumert

1 reference

23 August 2017

Guido Lammering

1

1 reference

23 August 2017

Ludy Lutgens

series ordinal

6

1 reference

23 August 2017

Piet van den Ende

series ordinal

7

1 reference

23 August 2017

Philippe Lambin

series ordinal

9

1 reference

23 August 2017

30 August 2010

1 reference

Strahlentherapie und Onkologie

23 August 2017

1 reference

23 August 2017

186

1 reference

23 August 2017

471-481

1 reference

23 August 2017

9

1 reference

https://scigraph.springernature.com/pub.10.1007/s00066-010-2150-1

23 August 2017

0 references

cites work

Stability of 18F-deoxyglucose uptake locations within tumor during radiotherapy for NSCLC: a prospective study.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2150-1

PET-CT fusion in radiation management of patients with anorectal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2150-1

Effect of 11C-methionine-positron emission tomography on gross tumor volume delineation in stereotactic radiotherapy of skull base meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2150-1

Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2150-1

The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2150-1

Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2150-1

Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2150-1

FDG-PET-based radiotherapy planning in lung cancer: optimum breathing protocol and patient positioning--an intraindividual comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2150-1

The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2150-1

11C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2150-1

Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2150-1

Tumor delineation based on time-activity curve differences assessed with dynamic fluorodeoxyglucose positron emission tomography-computed tomography in rectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2150-1

Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using (18)F-fluorodeoxyglucose-positron emission tomography-computed tomography imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2150-1

The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2150-1

The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2150-1

Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2150-1

Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2150-1

Cerebral glioma: evaluation with methionine PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2150-1

Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2150-1

Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2150-1

Feasibility of pathology-correlated lung imaging for accurate target definition of lung tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2150-1

(18)F-fluorodeoxyglucose positron emission tomography-based assessment of local failure patterns in non-small-cell lung cancer treated with definitive radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2150-1

PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2150-1

Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2150-1

Individualized Radical Radiotherapy of Non–Small-Cell Lung Cancer Based on Normal Tissue Dose Constraints: A Feasibility Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2150-1

Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer

21 January 2018

1 reference

12 December 2020

Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?

1 reference

12 December 2020

Can an FDG-PET/CT predict tumor clearance of the mesorectal fascia after preoperative chemoradiation of locally advanced rectal cancer?

1 reference

12 December 2020

Reduction of respiratory motion artifacts in PET imaging of lung cancer by respiratory correlated dynamic PET: methodology and comparison with respiratory gated PET.

1 reference

12 December 2020

Prognostic value of O-(2-18F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma.

1 reference

12 December 2020

Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings

1 reference

12 December 2020

Contribution of whole-body 18FDG PET imaging in the management of cervical cancer.

1 reference

12 December 2020

Evaluation of early metabolic responses in rectal cancer during combined radiochemotherapy or radiotherapy alone: sequential FDG-PET-CT findings

1 reference

12 December 2020

A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer.

1 reference

12 December 2020

Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma

1 reference

12 December 2020

Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography

1 reference

12 December 2020

Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancer

1 reference

12 December 2020

Modern multimodal neuroimaging for radiosurgery: the example of PET scan integration.

1 reference

12 December 2020

Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial.

1 reference

12 December 2020

Blood glucose level normalization and accurate timing improves the accuracy of PET-based treatment response predictions in rectal cancer

1 reference

12 December 2020

High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy.

1 reference

12 December 2020

Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study.

1 reference

12 December 2020

A contrast-oriented algorithm for FDG-PET-based delineation of tumour volumes for the radiotherapy of lung cancer: derivation from phantom measurements and validation in patient data

1 reference

12 December 2020

The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials

1 reference

12 December 2020

Limited additional value of positron emission tomography in staging oesophageal cancer.

1 reference

12 December 2020

(18)F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer

1 reference

12 December 2020

Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen

1 reference

12 December 2020

Target volume definition for 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer.

1 reference

12 December 2020

Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: Concepts and guidelines

1 reference

12 December 2020

Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: A planning study

1 reference

12 December 2020

Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study

1 reference

12 December 2020

Is FDG-PET scan in patients with early stage Hodgkin lymphoma of any value in the implementation of the involved-node radiotherapy concept and dose painting?

1 reference

12 December 2020

Detection of distant metastases in esophageal cancer with (18)F-FDG PET.

1 reference

12 December 2020

Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making.

1 reference

12 December 2020

PET/CT of skull base meningiomas using 2-18F-fluoro-L-tyrosine: initial report.

1 reference

12 December 2020

Use of stereotactic PET images in dosimetry planning of radiosurgery for brain tumors: clinical experience and proposed classification

1 reference

12 December 2020

Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer?

1 reference

12 December 2020

Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI

1 reference

12 December 2020

Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction.

1 reference

12 December 2020

18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.

1 reference

12 December 2020

Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma

1 reference

12 December 2020

A feasibility study of 18F-fluorodeoxyglucose positron emission tomography targeting and simultaneous integrated boost for intensity-modulated radiosurgery and radiotherapy

1 reference

12 December 2020

A biologically adapted dose-escalation approach, demonstrated for 18F-FET-PET in brain tumors

1 reference

12 December 2020

Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan

1 reference

12 December 2020

First experiences of radiation treatment planning with PET/CT

1 reference

12 December 2020

[(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma

1 reference

12 December 2020

Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma.

1 reference

12 December 2020

Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value

1 reference

12 December 2020

Transformation in the use of radiation therapy of Hodgkin lymphoma: new concepts and indications lead to modern field design and are assisted by PET imaging and intensity modulated radiation therapy (IMRT).

1 reference

12 December 2020

Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives

1 reference

12 December 2020

Involved-node radiotherapy in early-stage Hodgkin's lymphoma. Definition and guidelines of the German Hodgkin Study Group (GHSG).

1 reference

12 December 2020

Impact of (18)F-FDG-PET/CT on staging and irradiation of patients with locally advanced rectal cancer

1 reference

12 December 2020

Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma.

1 reference

12 December 2020

PET as a tool in the clinical evaluation of pituitary adenomas

1 reference

12 December 2020

Imaging: staging and evaluation of lymphoma using nuclear medicine

1 reference

12 December 2020

18F-fluoro-deoxyglucose positron emission tomography for post-treatment evaluation of malignant lymphoma: a systematic review.

1 reference

12 December 2020

Discrepancy between lesion distributions on methionine PET and MR images in patients with glioblastoma multiforme: insight from a PET and MR fusion image study

1 reference

12 December 2020

Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study.

1 reference

12 December 2020

Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.

1 reference

12 December 2020

Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalation.

1 reference

12 December 2020

The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study.

1 reference

12 December 2020

10.1007/S00066-010-2150-1

Identifiers

DOI

1 reference

23 August 2017

1 reference